Quest PharmaTech Inc., a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. The company's lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16 for the potential…
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-05-29
News release - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Transactions 2026-05-11 Financing
Other material contracts - English.pdf
Results 2025-12-22 Financials
Interim MD&A - English.pdf
Results 2025-12-22 Financials
Interim financial statements/report – English.pdf
Results 2025-09-26 Financials
Interim MD&A - English.pdf
Results 2025-09-26 Financials
Interim financial statements/report – English.pdf
News 2025-08-27
News release - English.pdf
Results 2025-06-27 Financials
Interim MD&A - English.pdf
Results 2025-06-27 Financials
Interim financial statements/report – English.pdf
News 2025-06-02
News release - English.pdf